Discover a unique style of learning!  Rivermont Collegiate will host a No Erasers! First Grade Open House Tuesday, March 2nd at 6:30 p.m. Interested families are invited to a presentation and conversation with First Grade Teacher Kathy Topalian about Rivermont's "No Erasers" approach, where students learn from their errors.  This informal setting is the perfect opportunity to watch your child interact with "Mrs. T" and learn more about the Rivermont philosophy!  Families are also invited to tour the Rivermont campus with Cindy Murray, Director of Admissions, who will be on hand to answer questions about Rivermont's philosophy, values, programs, and facilities.

Rivermont Collegiate provides an academically rigorous yet nurturing environment, where students develop skills and attitudes that provide the foundation for future learning.  Our gifted faculty provides students with the tools to pursue knowledge independently and take intellectual and artistic risks, while small class sizes ensure each child receives direction and feedback.  Come explore our approach!

For additional information on Rivermont Collegiate or Tuesday's No Erasers! First Grade Open House, contact Cindy Murray at (563) 359-1366 ext. 302 or murray@rvmt.org.  This event is free and open to the public.

WASHINGTON - Senator Chuck Grassley today said that the U.S. Department of Education has awarded a $44,834 grant to the Iowa Department of Education through the Test Fees program.

"These funds will help eligible low-income students receive college credits by helping them afford advanced placement test fees," Grassley said.

According to the U.S. Department of Education, the Iowa Department of Education will use the funds to help pay for 679 Advanced Placement tests and 30 International Baccalaureate tests that will be taken by low-income students this spring.

Each year, thousands of local Iowa organizations, colleges and universities, individuals and state agencies apply for competitive grants and loans from the federal government.  The funding is then awarded based on each local organization or individual's ability to meet criteria set by the federal entity.

###

 

WASHINGTON - Sen. Chuck Grassley, ranking member of the Committee on Finance, said he's stunned that 56 percent of able-bodied adults who receive welfare benefits are receiving zero education, job training, job search, substance abuse counseling or community service activities.

"This is a waste of potential and opportunity," Grassley said.  "Those receiving welfare benefits should be involved in education or job training to improve their economic prospects and income security.  Either states are failing these individuals, or they're failing themselves by not taking advantage of what's available to them."

Grassley highlighted the latest data released last week by the Department of Health and Human Services, Administration for Children and Families.  The department released the 2008 Temporary Assistance for Needy Families (TANF) participation data, the most recent information available.  The data show that despite minor improvements to encourage states to engage families receiving welfare in meaningful activities included in the Deficit Reduction Act of 2005, states are failing to engage work-ready adults in education, job training, job search, substance abuse counseling or community service activities.  According to the latest data, states report that 56 percent of able-bodied adults are engaging in zero job- or education-related activity.  The report is available here; the 56 percent figure is in Table 8B:

http://www.acf.hhs.gov/programs/ofa/particip/2008/index2008.htm

"This lack of activity is especially troubling during the tough economy," Grassley said.  "Welfare is an integral part of the social safety net.  The benefits are meant to be temporary, and welfare programs are supposed to help adults move away from welfare and onto something permanent.  During the bad economy, we can't afford to let any more people fall behind.  We should be using this time to prepare people for economic recovery."

Grassley said fostering a cycle of dependence where families receive welfare absent any activity or responsibility is not consistent with the landmark 1996 welfare reform bill.  A key principle of the bipartisan welfare bill was replacing an uncapped entitlement to welfare with a temporary program that encouraged work and work-related activities.

"There's obviously a lot more work to be done to ensure that families receiving welfare have the opportunity to make the transition from dependence to self-sufficiency," Grassley said.  "The authorization for TANF and related programs ends at the end of this fiscal year.  I call on the congressional leadership and the Administration to work with me this year to enact a bipartisan reauthorization of these programs that fixes the elements that aren't working for the people they're meant to help."

-30-

WASHINGTON - Senator Chuck Grassley is asking Wellmark for information about its plan to increase health insurance rates.

In a letter sent today, Grassley requested an accounting of the factors considered, including any independent actuarial analysis, data about reserves, and documentation of the insurer's effort, announced in 2007, to make itself a true nonprofit.

"I'm asking because Iowa consumers deserve to know, and as the health care debate in Washington continues, insurance rate increases are a major issue. The health reform legislation passed last year would not drive costs down.  In fact, health reform bills passed by the House and Senate would cause premiums to go up even more than they already would have gone up, according to the Congressional Budget Office," Grassley said.

The text of Grassley's letter to Wellmark is here.

 

February 23, 2010

Mr. John Forsyth

Chairman and Chief Executive Officer

Wellmark Blue Cross and Blue Shield

636 Grand Ave

Des Moines, IA 50309-2565

Dear Mr. Forsyth:

As the senior senator from Iowa and Ranking Member of the Senate Committee on Finance, I am writing regarding Wellmark Blue Cross and Blue Shield's plan to increase health insurance premiums by as much as 22 percent on April 1, 2010.  At a time of record unemployment rates and sluggish wage growth, I'm concerned that a rate increase of this magnitude could force some Iowans to drop health insurance entirely.  This would not only have a negative impact on the health of Iowa citizens, but could also place a greater financial burden on providers that will be forced to deliver more uncompensated care.

Recent reports have stated that Wellmark Blue Cross and Blue Shield plans to raise premiums by an average of 18 percent for approximately 80,000 of its 1.8 million customers.  This is almost twice as much as last year's 9.3 percent increase.  Moreover, some 44,000 Wellmark beneficiaries will see rate increases as high as 22 percent.  I'm particularly concerned about the level of these increases since the Centers for Medicare and Medicaid Services' Office of the Actuary recently reported that health care spending increased by a much lower rate of 5.7 percent in 2009.  I understand that the individual and small group health insurance markets face unique challenges regarding adverse selection and that the recent economic downturn has likely exacerbated these challenges.  However, I also believe Iowans deserve a clear explanation for why premiums are increasing at a much faster rate than national health care spending.

As Ranking Member of the Senate Committee on Finance, I take my oversight responsibilities very seriously and I have always believed that greater transparency allows consumers to make better choices.  Accordingly, in an effort to obtain more information about Wellmark's plan to increase health insurance rates on April 1, 2010, I ask that you respond to the following questions and requests by no later than March 8, 2010.  In responding, please repeat the question followed by the appropriate response.

1.   What factors were taken into consideration when coming up with the health insurance rates for 2010?

2.   Were the 2010 rates reviewed by any independent actuarial firms before being presented to the Iowa Insurance Division? If so, please provide a copy of this independent analysis and any supporting documentation.

3.   Please provide a report on Wellmark's average Medical Loss Ratio in its individual and small group products for each of the last five years along with a description and explanation of the factors involved.

4.   Please provide a report on the amount held in reserves for each year for the past five years along with an explanation of how Wellmark Blue Cross and Blue Shield's reserves compare to any minimum levels required by the Iowa Insurance Division, and whether Wellmark utilized any reserves to mitigate rate increases for 2010 or for any year within the five year period.

5.   In 2007, Wellmark announced its goal to be a pure non-profit and reduce profits to 0 percent. Please provide copies of Wellmark's Form 1120, U.S. Corporation Income Tax Return, for the past five years. Please also provide copies of all studies and reports used to determine compensation for the officers listed on Schedule E of Form 1120.

Thank you for your attention to this important matter.  While there are strong differences of opinion on how to improve the U.S. health care system, there is widespread agreement that health care spending levels are unsustainable.  Your answers to the questions listed above will not only be informative for Iowa consumers, but will also be helpful as Congress considers potential policy solutions.

Sincerely,

Charles E. Grassley

Ranking Member

 

Senator Chuck Grassley Statement Submitted to the Record

Partisan and Incomplete Processing of Bipartisan Economic Incentives Package

Monday, Feb. 22, 2010

The Senate is about to engage in a cloture vote on the Senate Democratic Leadership's third stimulus bill.  What I find surprising is that what we are about to vote on indisputably and absolutely belongs to the majority leader.  That is to say we are not going to vote on a bipartisan package that I put together with Finance Committee Chairman Baucus.  I was under the impression that the Senate Democratic Leadership was genuine in its desire to work on a bipartisan basis, but clearly I was mistaken.  Although the Senate Democratic Leader was highly involved in the development of a bipartisan bill, he arbitrarily decided to replace it with a bill he hopes to jam through the Senate.

As much as I was surprised by the Senate Democratic Leader's disregard for bipartisanship, I am even more surprised by the explanations given by him and his cohorts.

Perhaps the most significant change between the bipartisan package Chairman Baucus and I helped put together and the package we will be voting to move to is that a package of expired tax provisions has been removed.  Normally referred to as extenders, these generally very popular and certainly bipartisan provisions have been extended several times over the past few years.

What is surprising is that hyper-partisan members of the majority have suddenly decided that the tax extenders are partisan pork for Republicans.

A representative sample comes from one report, which describes the bipartisan bill as "an extension of soon-to-expire tax breaks that are highly beneficial to major corporations, known as tax extenders, as well as other corporate giveaways that had been designed to win GOP support."  Just today the Washington Post includes this attribution to the Senate Democratic Leadership.  From the Post:

" "We're pretty close," {the majority leader} said Friday during a television appearance in Nevada, adding that he thought quote, "fat cats", unquote, would have benefitted too much from the larger Baucus-Grassley bill."

The portrait being painted by certain members of the majority, echoed without critical examination in some press reports, is wildly inaccurate.

For one thing, the tax extenders include provisions such as the deduction for qualified tuition and related expenses and also the deduction for certain expenses of elementary and secondary school teachers.  If you are going to school or if you are a grade school teacher, the Senate Democratic Leadership thinks you are a fat cat so you are on your own.  If your house was destroyed in a recent natural disaster and you still need any of the temporary disaster relief provisions contained in the extenders package, too bad, because helping you would amount to a corporate giveaway in the eyes of some.

The tax extenders have been routinely passed repeatedly because they are bipartisan and very popular.  Democrats have consistently voted in favor of extending these tax provisions.

House Speaker Nancy Pelosi released a very strong statement upon House passage of tax extenders in December of 2009, saying this was, quote, "good for businesses, good for homeowners, and good for our communities," end quote.  December of 2009 was not very long ago.  In 2006, the then-Democratic Leader released a blistering statement, quote, "after Bush Republicans in the Senate blocked passage of critical tax extenders," end quote, because, quote, "American families and businesses are paying the price because this Do Nothing Republican Congress refuses to extend important tax breaks," end quote.  I ask unanimous consent that both of these statements be printed in the record in their entirety.

Recent bipartisan votes in the Senate on extending expiring tax provisions have come in the Emergency Economic Stabilization Act of 2008; the Tax Relief and Health Care Act of 2006, which passed the Senate by unanimous consent; and the Working Families Tax Relief Act of 2004, which originally passed the Senate by voice vote although the conference report received 92 votes in favor and a whopping 3 against.  According to the non-partisan Congressional Research Service, extension of several of these provisions go back even further, including the Tax Relief Extension Act of 1999, which again passed the Senate by unanimous consent  but lost 1 vote on the conference report.

Blinded and dazed by the power of their now not-so-super majority, certain Democrats have in the last few weeks turned against the extenders.  One Democrat said, quote, "Our side isn't sure that the Republicans are real interested in developing good policy and to move forward together.  Instead, they are more inclined to play rope-a-dope again.  My own view is, let's test them," end quote.  Another member of this large 59-vote majority exclaimed, quote, "It looks more like a tax bill than a jobs bill to me.  What the Democratic Caucus is going to put on the floor is something that's more focused on job creation than on tax breaks," end quote.

The only explanation for this behavior is that certain senators have decided that it serves a deeply partisan goal to slander what have been for several years bipartisan and popular tax provisions benefitting many different people.

Today's Washington Post article I quoted from earlier includes a statement from a Senate Democratic leadership aide saying that, quote, "No decisions have been made, but anyone expecting us immediately to go back to a bill that includes tax extenders will be sorely disappointed," end quote.

Having put their heads into the sand, this chamber's Democratic leaders seem intent on keeping them there. I appeal to all of you to vote against the Democratic Leadership's effort today to jam the Senate.  A vote for the Senate Democratic Leadership's cloture motion is a vote to foreclose an opportunity to improve the bill.  It also is a vote to forbid any corrections to mistakes in the bill.  And there is a significant mistake in the Senate Democratic Leadership's bill.  The bill as currently written would allow employers of illegal workers to benefit from the payroll tax holiday.  We should correct that mistake with an amendment.  The Senate Democratic Leadership's posture prohibits this correction.

Either the Democratic leaders are playing partisan politics with tax extenders, or they don't understand the worth of the provisions to the economy, including job retention and creation.  The biodiesel industry alone says 23,000 jobs are at risk due to the biodiesel tax credit being allowed to expire.  Those workers are not fat cats.

And in case anyone thinks biodiesel is something only Iowans worry about, these green jobs are in forty-four of the fifty states.  There are 24 facilities in Texas.  There are 15 facilities in Iowa.  There are 6 facilities in Illinois and 6 in Missouri.  There are 4 facilities in Washington.  Ohio has 11 facilities.  There are 5 facilities in Indiana.  There are 3 facilities each in Mississippi and South Carolina.  There are 7 facilities in Pennsylvania and 4 in Arkansas.  New Jersey has 2 facilities.

There is one facility in North Dakota. Only 6 of the 50 states do not have some biodiesel production.  They are Alaska, Delaware, Maine, New Hampshire, Vermont, and Wyoming.  The other forty-four states have some biodiesel presence.   I ask unanimous consent to put in the record an article from the Erie, Pennsylvania, newspaper, describing the struggles of a local biodiesel plant.

So we need to turn away from talk of fat cats. We need to get back to work on the bipartisan package that was in the works until the Senate Democratic Leadership's dramatic change in direction.  Many people who are not fat cats or a part of large corporations are counting on these provisions being extended, and they are counting on their elected representatives to work together, as we were doing, to get the job done.

###

Who: Vollara

What: Learn how to connect and find hope both financially and physically. Come experience "Green technologies" by smelling, tasting and feeling Better Living Products.

When: Friday, March 5th, 6-9 pm and Saturday March 6th, 9 am- 5 pm

Where: The Lodge 900 Spruce Hills Dr. Bettendorf , IA 52722

(Quad Cities, IL /IA) A new company based in Dallas, TX - VOLLARA - will be sharing with the Quad Cities community how they can experience: uncompromising health, freedom to hope, and the ability to become "difference makers" for the community/planet. Bill Coyle, Vice-President of Sales, will be at The Lodge on March 5th and 6th to launch this global opportunity in the Quad Cities.

Vollara offers a comprehensive range of products in three categories: weight management, wellness supplements, and environmental purity. All of these products together form the basis for Uncompromising Health, a platform on which Vollara's products are based. "Uncompromising Health" is about becoming healthy from the inside out and the outside in.

The Vollara products offer complete health choices, not partial ones; choices to purify and enrich the air you breathe, the surfaces you touch, the water you drink. Moreover, there are choices to support one's immune system, to strengthen one's body, and to shape one's physique for optimal resistance and wellness. Furthermore, their proven business systems empower people to command their financial footing, to bring security to their lives, to provide for themselves and their loved ones and to help all of us share and care for this precious planet we have been blessed with.

Kelly Davis & Barb Catlin - Business Developers and local leaders with Vollara states, "Make 2010 the year to become well - both physically and financially and come experience what Vollara has to offer. This event on the 5th and 6th of March will allow our community to participate in the making of history as this global company launches here in the Quad Cities."

###

WASHINGTON, D.C. - Senator Tom Harkin (D-IA) today issued the following statement after the White House unveiled their health reform proposal.  Harkin is Chairman of the Senate Health, Education, Labor and Pensions Committee.

"In his State of the Union address, the President made clear that we cannot walk away from health reform.  Today, the President put this directive into action and he did so with a proposal that builds on what works, fixes what does not and moves the health reform debate ahead. 

"The president's plan seeks to increase affordability and expand access to health care, fill the donut hole so seniors can afford essential medications and ensure fairness across the board with state Medicaid programs.  It also recognizes that states should be seen as innovators for expanding Medicaid coverage to their poorest residents and does not penalize these states in favor of states that have done little or nothing to extend benefits to the uninsured.  Additionally it provides a safeguard against substantial premium rate hikes to protect consumers.

"With a framework in hand and a bipartisan summit on the horizon, the White House has outlined a path forward for enacting comprehensive health reform this year.   I look forward to joining with our president in this effort and hope that it is met with strong support in Congress."
The Interstate 80 bridge over the Mississippi River will handle only westbound traffic starting April 5. It is the hope of the DOT that the bridge will return to two-way traffic as early as June 15, if work on the eastbound span is completed by then. The repair contract includes incentives for early completion of the work.

WASHINGTON - Senator Max Baucus, Chairman of the Committee on Finance, and Senator Chuck Grassley, Ranking Member, today released a committee report based on a two-year inquiry of the diabetes drug Avandia. The senators also asked the Food and Drug Administration to describe what steps the agency has taken to protect patients in an ongoing Avandia clinical trial, and why the study is allowed to continue, given that the FDA itself estimated that the drug caused approximately 83,000 excess heart attacks between 1999 and 2007.  In 2008, FDA officials called the clinical trial, as then-designed, "unethical and exploitative" of patients.

"There's a real problem when FDA's office that reviews drugs that are on the market is an unequal player in drug safety efforts," Grassley said.  "It doesn't make any sense to have these experts, who study drugs after they have been on the market for several years, under the thumb of the officials who approved the drug in the first place and have a natural interest in defending that decision.  The Avandia case may be the most alarming example of the problem with this set-up.  Both the FDA and Congress need to take every step possible to establish independence for post-market surveillance. The Institute of Medicine has made recommendations.  It's a matter of sound science and public safety."

"Americans have a right to know there are serious health risks associated with Avandia and GlaxoSmithKline had a responsibility to tell them.  Patients trust drug companies with their health and their lives and GlaxoSmithKline abused that trust," Baucus said.  "We will continue watching closely and working with the FDA to make sure patients and doctors are aware of the risks associated with Avandia and all drugs so they can make safe and informed decisions when choosing their medicines."

The committee report explores when the Avandia manufacturer, GlaxoSmithKline, became aware of heart attack risks associated with the drug, whether the company sufficiently warned patients and the FDA of the dangers, and steps the company apparently took to create doubt regarding negative findings about the drug.

The report was developed over the last two years by committee investigators who reviewed more than 250,000 pages of documents provided by GlaxoSmithKline, the FDA, and several research institutes.  Committee investigators also conducted numerous interviews and phone calls with GlaxoSmithKline, the FDA and anonymous whistleblowers.  The report can be found at http://finance.senate.gov.

Baucus and Grassley directed the report over concerns that Avandia and other high-profile drugs such as Vioxx put public safety at risk because the FDA has been too cozy with drug makers and has been regularly outmaneuvered by companies that have a financial interest in downplaying or under-exploring potential safety risks.  In 2007, Congress enacted legislation giving the FDA some new tools to better protect patients from harm caused by drugs that are brought to market without sufficient safety oversight or consumer warnings. However, the legislation did not fix a fundamental problem at the FDA -- the imbalance between the office responsible for monitoring the safety of drugs after approval and the office that puts drugs on the market in the first place.

The FDA has overlooked or overridden safety concerns cited by its own officials, as appears to be the case with the ongoing Avandia study.  The text of the Baucus-Grassley letter to the FDA on the Avandia study follows here.  The letter with attachments is at http://finance.senate.gov.

February 18, 2010

The Honorable Margaret A. Hamburg, MD, Commissioner

U.S. Food and Drug Administration

White Oak Building 1

10903 New Hampshire Avenue

Silver Spring, MD 20993

Dear Commissioner Hamburg:

As senior members of the United States Senate and Chairman and Ranking Member of the Committee on Finance (Committee), we have a duty under the Constitution to conduct oversight into the actions of executive branch agencies, including the Food and Drug Administration (FDA).  In this capacity, we must ensure that FDA properly fulfill their mission to advance the public's welfare, safeguard the nation's drug supply, and protect patients participating in clinical trials.

We recently released a report raising concerns about Avandia, a diabetes drug made by GlaxoSmithKline (GSK).  We began this inquiry after the New England Journal of Medicine published a study in May 2007 warning of the possible cardiovascular risk of Avandia.

Our report was based on a review of hundreds of thousands of pages of internal GSK documents and concluded:

The totality of evidence suggests that GSK was aware of the possible cardiac risks associated with Avandia years before such evidence became public. Based on this knowledge, GSK had a duty to sufficiently warn patients and the FDA of its concerns in a timely manner. Instead, GSK executives intimidated independent physicians, focused on strategies to minimize findings that Avandia may increase cardiovascular risk, and sought ways to downplay findings that the rival drug ACTOS (pioglitazone) might reduce cardiovascular risk.

In 2007, the FDA asked GSK to perform a cardiovascular safety trial, called TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation), to compare Avandia to other diabetes treatments such as ACTOS (piolglitazone).  According to clinicaltrials.gov, the TIDE trial is currently recruiting patients. [ATTACHMENT A]

In response to several document requests made to the FDA, we received and reviewed an analysis conducted by two FDA safety officials.  It is our understanding that this analysis, conducted in October 2008, reviewed all available studies comparing rosiglitazone (Avandia) to pioglitazone (ACTOS).  The analysis by these FDA officials raise some alarms.  For instance, they wrote:

[T]here is no evidence that rosiglitazone confers any unique health benefits over pioglitazone while there is strong evidence that rosiglitazone confers an increased risk of   [heart attacks] and heart failure compared to pioglitazone.  [ATTACHMENT B]

Even more alarming, they concluded that "any proposed head-to-head trial of rosiglitazone vs. pioglitazone would be unethical and exploitative."

Two days after releasing this analysis, one of these same safety officers reviewed the protocol for the TIDE trial. This safety officer wrote that because of cardiovascular concerns with Avandia "the safety of the study itself cannot be assured, and is not acceptable." [Attachment C]

After reading these documents, we would like to know what steps the FDA has taken to protect patients in the TIDE trial, and why this trial is allowed to continue.  We would also like to know if the Office for Human Research Protection (OHRP) was notified about the safety concerns of the TIDE trial identified by the FDA.  Further, we were alarmed to learn that the warnings from these safety officers do not appear to be addressed in the consent form that was handed out to patients that were enrolled in the study.  [Attachment D]

We look forward to hearing from you by no later than March 4, 2010.

Sincerely,

Max Baucus, Chairman

Chuck Grassley, Ranking Member

Pages